†<p>Number of subjects included in PK and PD population (N (%)): 4 (67%). Samples from 2 subjects were unusable because they had thawed in transit to the analytical laboratory.</p><p><b>Abbreviations:</b> AE, Adverse Event.</p
<p>Abbreviations: AE = adverse event, FBS = fetal bovine serum, GVHD = graft versus host disease, MR...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...
<p>Abbreviations: AE, adverse event.</p>a<p>Expressed as <i>n</i> and percent of total subjects in e...
<p>AD = atopic dermatitis; n = number of subjects in the specified category; FAS = full analysis set...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
* Of the 6 subjects not treated, 4 subjects did not wish to continue due to reasons unrelated to ass...
<p>Abbreviations: ALT, alanine aminotransferase; ULN, upper limit of normal range.</p>a<p>Not all la...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Of 242 screened volunteers, 120 subjects were assessed eligible for enrollment, allocated to one ...
<p>Serious adverse events in patients who completed all pharmacokinetic assessments (N = 25) and in ...
<p>Subjects included into the study, their allocation to pulmonary disease categories and subcategor...
<p>Values are presented as n (% of group). * One patient developed lung cancer 2 years and 9 months ...
Patient disposition. AE = Adverse event; AmB = liposomal amphotericin B; EOT = End of treatment; mIT...
<p>Abbreviations: AE = adverse event, FBS = fetal bovine serum, GVHD = graft versus host disease, MR...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...
<p>Abbreviations: AE, adverse event.</p>a<p>Expressed as <i>n</i> and percent of total subjects in e...
<p>AD = atopic dermatitis; n = number of subjects in the specified category; FAS = full analysis set...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
* Of the 6 subjects not treated, 4 subjects did not wish to continue due to reasons unrelated to ass...
<p>Abbreviations: ALT, alanine aminotransferase; ULN, upper limit of normal range.</p>a<p>Not all la...
<p>Local adverse events that were reported twice by individual subjects (8 adverse events) in the se...
<p>Number and percentages of subjects showing adverse events after administration of drugs in differ...
<p>N = number of subjects in the specified group; n = number of subjects in the specified category (...
<p>Of 242 screened volunteers, 120 subjects were assessed eligible for enrollment, allocated to one ...
<p>Serious adverse events in patients who completed all pharmacokinetic assessments (N = 25) and in ...
<p>Subjects included into the study, their allocation to pulmonary disease categories and subcategor...
<p>Values are presented as n (% of group). * One patient developed lung cancer 2 years and 9 months ...
Patient disposition. AE = Adverse event; AmB = liposomal amphotericin B; EOT = End of treatment; mIT...
<p>Abbreviations: AE = adverse event, FBS = fetal bovine serum, GVHD = graft versus host disease, MR...
†<p>All subjects were supposed to be on diet and exercise treatment, but 1 subject reported the use ...
<p>Abbreviations: AE, adverse event.</p>a<p>Expressed as <i>n</i> and percent of total subjects in e...